1UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Laucet. 1998,352: 854-865.
2Laure CM, Ilkka V, Riitta MK, et al. Endocrine and metabolic effects of metformin versus ethinyl estrddiol-cyproterone acetate in obese women with polycystic ovmy syndrome: a randomized study 1. J Cliu Endocrinol Metab, 2000,85:3161-3168.
3Lee A, Morley JE. Metformin decreases food consumption and induces weight loss in subjects with obesity with type Ⅱ non-insulin-dependent diabetes. Obes Res, 1998,6:47-53.
4Kosegawa I, Katayama S, Kikuchi C, et al. Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance. Hypertens Res, 1996,19:37--41.
5Glueck C J, Fontaine RN, Wang P, et al. Mefformin reduces weight,centripetal obesity, insulin, leptin and low-density lipoprotein cholesterol in nondiabetic morbidly obese subjects with body mass index greater than 30. Metabolism, 2001:50:856-861.
